Cardio DiagnosticsCDIO
Market Cap: $6.98M
About: Cardio Diagnostics Holdings Inc is a biotechnology company that makes cardiovascular disease prevention and early detection more accessible, personalized, and precise. The company was formed to further develop and commercialize a proprietary artificial intelligence-driven integrated Genetic-Epigenetic EngineTM for cardiovascular disease to become the leading medical technology company for enabling improved prevention, early detection, and assistance in the treatment of cardiovascular disease.
Employees: 9
Fund manager confidence
Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)
100% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 2
14% more funds holding
Funds holding: 14 [Q1] → 16 (+2) [Q2]
0.08% more ownership
Funds ownership: 7.9% [Q1] → 7.98% (+0.08%) [Q2]
57% less capital invested
Capital invested by funds: $2.3M [Q1] → $996K (-$1.31M) [Q2]
Research analyst outlook
1 Wall Street Analyst provided 1 year price targets over the past 3 months
1 analyst rating
Benchmark Bruce Jackson 27% 1-year accuracy 13 / 48 met price target | 590%upside $2 | Speculative Buy Reiterated | 27 Aug 2024 |